• +353-1-416-8900(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)
China Diagnostic Reagent Industry Report, 2013-2015 - Product Image

China Diagnostic Reagent Industry Report, 2013-2015

  • Published: October 2013
  • Region: China
  • 81 Pages
  • Research In China
China Diagnostic Reagent Market Size Hit RMB 13.3 Billion In 2012

Driven by huge population base, intensified aging and many favorable policies, China diagnostic reagent industry has been developing rapidly. In 2008-2012, the diagnostic reagent market size presented the CAGR of over 15%, hitting RMB13.3 billion with the year-on-year growth rate of 16.7% in 2012. Moreover, the market will accelerate its pace in the wake of China's medical reform, enhanced health awareness of people and improved physical examination technology.

In China, in vitro diagnostic reagents consist of biochemical diagnostic reagents, immune diagnostic reagents, molecular diagnostic reagents and hematology diagnostic reagents. Biochemical and immune diagnostic reagents enjoyed the highest 70% market share together in 2012, which was determined by the domestic medical demand. Chinese economy and the government medical expenditure stay at a low level, which affects the medical diagnosis consumption seriously.

From now to the next three years, China will desire regular tests mostly, which have the most demand for biochemical and immune diagnostic reagents. The progress in Chinese diagnosis technology and the increase of high-end consumers will boost the demand for READ MORE >

1 Overview of Diagnostic Reagent Industry
1.1 Definition
1.2 Classification
1.3 Industry Chain

2 Status Quo of China Diagnostic Reagent Industry
2.1 Overview
2.2 Market Structure
2.3 Import and Export
2.3.1 Import
2.3.2 Export
2.4 Competition Pattern
2.5 Market Segments
2.5.1 Biochemical Diagnostic Reagents
2.5.2 Immunodiagnostic Reagents
2.5.3 Molecular Diagnostic Reagent
2.5.4 Comprehensive In Vitro Diagnostic Reagents
2.6 Profit Level

3 Development Forecast of China Diagnostic Reagent Industry
3.1 Overall Forecast
3.1.1 The release of a number of favorable policies is conducive to the development of the diagnostic reagent industry
3.1.2 Large population base and enhanced aging promote the growth of the diagnostic reagent market
3.1.3 The government's medical and health expenditure keeps increasing
3.1.4 The number of outpatients maintains stable growth
3.1.5 Great Development Potentials of Detectable Items
3.1.6 Market Scale Forecast
3.2 Development Trends of Diagnostic Reagent Industry
3.2.1 Biochemical Diagnosis and Immunodiagnosis Will Still Be the Mainstream
3.2.2 Industry Concentration Will Increase
3.2.3 Enterprises with Complete Product Line Integrating Reagents and Instruments will Win

4 Major Chinese Diagnostic Reagent Enterprises
4.1 Shanghai Kehua Bio-engineering Co., Ltd. (KHB)
4.1.1 Profile
4.1.2 Operation
4.1.3 Revenue Structure
4.1.4 Gross Margin
4.1.5 R & D and Investment
4.1.6 Clients
4.1.7 In Vitro Diagnostics Business
4.1.8 Forecast and Prospect
4.2 Da An Gene Co., Ltd.
4.2.1 Profile
4.2.2 Operation
4.2.3 Revenue Structure
4.2.4 Gross Margin
4.2.5 Clients and Suppliers
4.2.5 R & D and Investment
4.2.6 Diagnostic Reagent Business
4.2.7 Forecast and Prospect
4.3 Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
4.3.1 Profile
4.3.2 Operation
4.3.3 Revenue Structure
4.3.4 Gross Margin
4.3.5 R & D and Investment
4.3.6 Diagnostic Reagent Business
4.3.7 Forecast and Prospect
4.4 BioSino Bio-technology and Science Inc.
4.4.1 Profile
4.4.2 Operation
4.4.4 R & D and Investment
4.4.5 Forecast and Prospect
4.5 Beijing Kinghawk Pharmaceutical Co., Ltd.
4.5.1 Profile
4.5.2 Operation
4.5.3 Revenue Structure
4.5.4 Gross Margin
4.5.5 Forecast and Prospect
4.6 Livzon Pharmaceutical Group Inc.
4.6.1 Profile
4.6.2 Operation
4.6.3 Revenue Structure
4.6.4 Gross Margin
4.6.5 Diagnostic Reagent Business
4.6.6 Forecast and Prospect
4.7 Beijing Leadman Biochemistry Co., Ltd.
4.7.1 Profile
4.7.2 Operation
4.7.3 Revenue Structure
4.7.4 Gross Margin
4.7.5 R & D and Investment
4.7.6 Clients
4.7.7 Forecast and Prospect
4.8 Changsha Sinocare Inc.
4.8.1 Profile
4.8.2 Operation
4.8.3 Revenue Structure
4.8.4 Gross Margin
4.8.5 R & D and Investment
4.8.6 Development Forecast
4.9 Bohui Innovation Technology Co., Ltd.
4.9.1 Profile
4.9.2 Operation
4.9.3 Revenue Structure
4.9.4 Gross Margin
4.9.5 R & D and Investment
4.9.6 Clients
4.9.7 Development Forecast
4.10 Others
4.10.1 Shinva Group
4.10.2 Humanwell Healthcare

Selected Charts

Major In Vitro Diagnostic Reagent Types (by Test Principle or Method)
In Vitro Diagnostic Reagent Types and Products (by National Policy)
Diagnostic Reagent Industry Chain
Revenue of China Biological Product Industry, 2005-2012
Chinese In Vitro Diagnostic Reagent Market Size, 2007-2013
Chinese In Vitro Diagnostic Reagent Market Structure, 2012
China's Diagnostic Reagent Import Volume, 2008-2013
China's Diagnostic Reagent Import Value, 2008-2013
China's Diagnostic Reagent Import Price, 2008-2013
China's Diagnostic Reagent Import Volume and Value by Country or Region, 2012-1013
China's Diagnostic Reagent Export Volume, 2008-2013
China's Diagnostic Reagent Export Value, 2008-2013
China's Diagnostic Reagent Export Price, 2007-2013
Top 10 Export Destinations of Chinese Diagnostic Reagents by Export Volume and Value, 2012-2013
Diagnostic Instrument Contrast between Domestic and Foreign Enterprises
Competition Pattern of China Diagnostic Reagent Industry
Revenue and Market Share of Some Chinese In Vitro Diagnosis Companies, 2012
IVD Gross Margin of Some Chinese Diagnostic Reagent Companies, 2008-2013
Major Policies of China Diagnostic Reagent Industry, 2010-2013
Population of 65-year-old People and Proportion in Total Population in China, 1982-2012
Two-week Prevalence Rate of People at All Ages in China
Total Medical & Health Costs and Proportion in GDP in China, 1980-2012
Chinese Medical & Health Cost Structure, 2008-2011
Number of Hospitals in China, 2005-2013
Number of Hospitals in China (by Grade), 2012
Diagnoses of Chinese Hospitals, 2005-2013
Chinese In Vitro Diagnostic Reagent Market Size, 2012-2015E
In Vitro Diagnostic Reagent Product Structure in China, 2015E
Products and Revenue of Major Global Diagnostic Reagent Companies
Development Process of Roche Diagnostics
Integrated Development Strategy of Global Leading Diagnostic Reagent Companies
KHB's Revenue and Net Income, 2008-2013
KHB's Operating Revenue (by Product), 2008-2013
KHB's Operating Revenue (by Region), 2010-2013
KHB's Gross Margin (by Product), 2008-2013
R&D Costs and % of Total Revenue of KHB, 2008-2012
KHB's New Products, by Jul 2013
KHB's Revenue from Top 5 Clients and % of Total Revenue, 2008-2013
Name List and Revenue Contribution of KHB's Top 5 Clients, 2012-2013
Name List and Procurement of KHB's Top 5 Suppliers, 2012
KHB's Diagnostic Reagent Revenue Structure, 2012
KHB's Medical Instrument Types and Products, 2012
KHB's Revenue and Net Income, 2012-2015E
Revenue and Profit of Da An Gene, 2008-2013
Operating Revenue of Da An Gene (by Product), 2008-2013
Revenue Structure of Da An Gene (by Region), 2008-2013
Gross Margin of Da An Gene (by Product), 2008-2013
Name List and Revenue Contribution of Top 5 Clients of Da An Gene, 2012-2013
Name List and Procurement of Top 5 Suppliers of Da An Gene, 2012
R&D Costs and % of Total Revenue of Da An Gene, 2010-2012
Reagent Revenue and Gross Margin of Da An Gene, 2008-2013
Instrument Revenue and Gross Margin of Da An Gene, 2008-2013
Principal Assets and Business of Da An Gene
Industrial Chain Layout of Da An Gene
Revenue and Net Income of Da An Gene, 2012-2015E
Revenue and Net Income of Fosun Pharmaceutical, 2008-2013
Operating Revenue of Fosun Pharmaceutical (by Product), 2008-2013
Revenue of Fosun Pharmaceutical (by Region), 2008-2013
Gross Margin of Fosun Pharmaceutical (by Product), 2008-2013
R&D Costs and % of Total Revenue of Fosun Pharmaceutical, 2008-2013
Revenue and Net Income of Fosun Pharmaceutical, 2012-2015E
Revenue and Annual Profit of BioSino Bio-technology and Science, 2008-2013
R&D Costs and % of Total Revenue of BioSino Bio-technology and Science, 2008-2013
Revenue and Profit of BioSino Bio-technology and Science, 2012-2015E
Revenue and Net Income of Kinghawk Pharmaceutical, 2008-2013
Revenue of Kinghawk Pharmaceutical (by Product), 2010-2013
Gross Margin of Kinghawk Pharmaceutical (by Product), 2010-2012
Revenue and Net Income of Kinghawk Pharmaceutical, 2012-2015E
Livzon's Revenue and Net Income, 2008-2012
Livzon's Operating Revenue (by Product), 2008-2013
Livzon's Revenue (by Region), 2008-2013
Livzon's Gross Margin (by Product), 2008-2013
Major Diagnostic Reagent Products of Livzon
Revenue and Gross Margin of Livzon's Diagnostic Reagent and Equipment, 2008-2013
Livzon's Revenue and Net Income, 2012-2015E
Leadman's Revenue and Net Income, 2008-2013
Leadman's Operating Revenue (by Product), 2008-2013
Leadman's Operating Revenue (by Region), 2011-2013
Leadman's Gross Margin (by Product), 2008-2013
R&D Costs and % of Total Revenue of Leadman, 2008-2013
Leadman's Revenue from Top 5 Clients and % of Total Revenue, 2008-2013
Name List and Revenue Contribution of Leadman's Top 5 Clients, 2012-2013
Number of Leadman's Dealers, 2008-2012
Leadman's Revenue and Net Income, 2012-2015E
Sinocare's Revenue and Net Income, 2009-2013
Sinocare's Capacity, Output and Sales Volume, 2009-2011
Sinocare's Blood Sugar Testing Instrument and Strip Sales Price (by Type), 2009-2011
Sinocare's Operating Revenue (by Product), 2009-2013
Sinocare's Revenue (by Region), 2009-2013
Sinocare's Gross Margin (by Product), 2009-2011
R&D Costs and % of Total Revenue of Sinocare, 2010-2013
Revenue and Net Income of Sinocare, 2012-2015E
Revenue and Net Income of Bohui Innovation, 2010-2013
Output, Sales Volume and Inventory of Bohui Innovation, 2011-2012
Revenue of Bohui Innovation (by Product), 2010-2013
Gross Margin of Bohui Innovation (by Product), 2010-2013
R&D Costs and % of Total Revenue of Bohui Innovation, 2010-2013
Fund-raising Projects and Capacity of Bohui Innovation
Name List, Revenue Breakdown and Percentage of Clients of Bohui Innovation, 2012-2013
Revenue and Net Income of Bohui Innovation, 2012-2015E
Revenue and Net Income of Shinva, 2008-2012
Revenue and Profit of Humanwell Healthcare, 2007-2013

Note: Product cover images may vary from those shown

ALSO AVAILABLE IN THE FOLLOWING LANGUAGES

RELATED PRODUCTS

Our Clients

Our clients' logos